Wells Fargo raised the firm’s price target on Tenet Healthcare (THC) to $205 from $195 and keeps an Overweight rating on the shares. Following Q3 earnings, the firm is updating models and detailed earnings bridges for each Hospital. Wells note that core revisions are for the most part relatively small, but there are impacts from Hurricane impacts and revised Medicaid supplemental payment assumptions that drive changes.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on THC:
- Tenet Healthcare price target raised to $190 from $180 at Truist
- Tenet Healthcare price target raised to $177 from $168 at Cantor Fitzgerald
- Tenet Healthcare price target raised to $217 from $197 at UBS
- Tenet Healthcare price target raised to $183 from $174 at RBC Capital
- Tenet Healthcare Reports Strong Q3 Results and Raises Outlook
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
